SE319173B - - Google Patents

Info

Publication number
SE319173B
SE319173B SE2031/64A SE203164A SE319173B SE 319173 B SE319173 B SE 319173B SE 2031/64 A SE2031/64 A SE 2031/64A SE 203164 A SE203164 A SE 203164A SE 319173 B SE319173 B SE 319173B
Authority
SE
Sweden
Application number
SE2031/64A
Inventor
G Nomine
R Bucourt
A Pierdet
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Priority claimed from FR974762A external-priority patent/FR1514075A/fr
Publication of SE319173B publication Critical patent/SE319173B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes
SE2031/64A 1963-02-20 1964-02-19 SE319173B (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
FR925431A FR1426077A (fr) 1963-02-20 1963-02-20 Nouveau dérivé estratriénique et procédé de préparation
FR940549A FR1453214A (fr) 1963-02-20 1963-07-05 Nouveaux dérivés stéroïdes insaturés et procédés de préparation
FR949609A FR3060M (fr) 1963-02-20 1963-10-04 Nouveau médicament doué notamment d'activité hypocholestérolémiante.
FR949608A FR3069M (fr) 1963-02-20 1963-10-04 Nouveau médicament notamment pour le traitement des troubles de l'anabolisme protidique.
BE644138A BE644138A (fr) 1963-02-20 1964-02-20
FR974762A FR1514075A (fr) 1964-02-17 1964-05-15 Nouveau dérivé stéroïde triénique et procédé de préparation
FR985285A FR3804M (fr) 1963-02-20 1964-08-14 Nouveau médicament notamment pour le traitement des troubles dus a une insuffisance de sécrétion du corps jaune.
FR19090A FR1492782A (fr) 1963-02-20 1965-06-01 Nouveau dérivé stéroïde insaturé et procédé de préparation
FR29732A FR5235M (fr) 1963-02-20 1965-08-27

Publications (1)

Publication Number Publication Date
SE319173B true SE319173B (fr) 1970-01-12

Family

ID=27575680

Family Applications (3)

Application Number Title Priority Date Filing Date
SE2031/64A SE319173B (fr) 1963-02-20 1964-02-19
SE15132/67A SE323073B (fr) 1963-02-20 1964-02-19
SE7432/66A SE323071B (fr) 1963-02-20 1966-05-31

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE15132/67A SE323073B (fr) 1963-02-20 1964-02-19
SE7432/66A SE323071B (fr) 1963-02-20 1966-05-31

Country Status (11)

Country Link
US (2) US3248294A (fr)
BE (1) BE644138A (fr)
BR (2) BR6456982D0 (fr)
CH (2) CH429713A (fr)
DE (2) DE1291337B (fr)
DK (1) DK117957B (fr)
FR (8) FR1426077A (fr)
GB (2) GB1048231A (fr)
NL (6) NL6401555A (fr)
OA (2) OA01428A (fr)
SE (3) SE319173B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3424745A (en) * 1964-05-27 1969-01-28 Roussel Uclaf Novel process for the preparation of trienic steroid derivatives
US3346454A (en) * 1964-11-04 1967-10-10 Roussel Uclaf 17-alkyl-19-nor-delta4, 9, 11-pregnatriene-3, 20-diones, process and intermediates for preparing same and therapeutic compositions thereof
US3422121A (en) * 1965-08-13 1969-01-14 Merck & Co Inc Process for the preparation of 13-lower alkyl-gona-4,8(14),9-triene-3,17-dione
US3424769A (en) * 1966-04-04 1969-01-28 Syntex Corp Process for the preparation of novel 6alpha-methyl-delta4,9(10)- diene steroids
NL129638C (fr) * 1966-08-12
US3461118A (en) * 1966-10-17 1969-08-12 Syntex Corp 3beta-tetrahydrofuranyloxy - and 3beta-tetrahydropyranyloxyestra - 4,9(10) - dienes and -4,9(10),11-trienes,their preparation and intermediates thereof
US3760073A (en) * 1971-06-09 1973-09-18 Roussel Uclaf Treatment of wounds
FR2162268A1 (en) * 1971-12-08 1973-07-20 Roussel Uclaf 6-alpha, 17-beta-dihydroxy-13-beta-ethyl-17-alpha - -ethynylgona-4,9,11-triene-3-one - with anti oesterogenic anti-lh and
FR2407940A1 (fr) * 1977-11-08 1979-06-01 Roussel Uclaf Nouveaux derives steroides 17 a-aryle, ou 17 a-heteroaryle, leur procede de preparation et leur application comme medicament
HU201091B (en) * 1985-12-26 1990-09-28 Mitsubishi Chem Ind Process for producing gonatriene derivatives and pharmaceutical compositions comprising same
HU203667B (en) * 1986-12-11 1991-09-30 Roussel Uclaf Process for producing synergetic zootechnical compositions containing three components
DE4232521A1 (de) * 1992-09-22 1994-03-24 Schering Ag Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
FR2696641B1 (fr) * 1992-10-13 1997-07-04 Roussel Uclaf Nouvelle utilisation de l'altrenogest.
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
CN101704871B (zh) * 2009-12-01 2012-05-23 北京紫竹药业有限公司 甾体化合物及其用途

Also Published As

Publication number Publication date
FR2713M (fr) 1964-08-10
FR1453214A (fr) 1966-06-03
BR6680069D0 (pt) 1973-12-26
GB1048231A (en) 1966-11-16
CH467255A (fr) 1969-01-15
SE323071B (fr) 1970-04-27
NL6607609A (fr) 1966-12-02
DK117957B (da) 1970-06-22
NL124135C (fr)
DE1291337B (de) 1969-03-27
OA01428A (fr) 1969-07-04
GB1048232A (en) 1966-11-16
BE644138A (fr) 1964-08-20
FR1426077A (fr) 1966-01-28
OA01429A (fr) 1969-07-04
NL6401555A (fr) 1964-08-21
FR3060M (fr) 1965-01-11
FR3069M (fr) 1965-01-18
FR1492782A (fr) 1967-08-25
US3257278A (en) 1966-06-21
US3248294A (en) 1966-04-26
BR6456982D0 (pt) 1973-08-14
FR3804M (fr) 1966-01-03
SE323073B (fr) 1970-04-27
NL6615432A (fr) 1967-01-25
FR5235M (fr) 1967-07-17
CH429713A (fr) 1967-02-15
NL126190C (fr)
DE1593307A1 (de) 1970-07-23
NL127247C (fr)

Similar Documents

Publication Publication Date Title
AT260747B (fr)
BE627012A (fr)
BE641275A (fr)
BE627172A (fr)
BE462764A (fr)
BE465565A (fr)
BE507458A (fr)
BE533484A (fr)
BE547422A (fr)
BE640672A (fr)
BE582314A (fr)
BE603935A (fr)
BE608372A (fr)
BE612803A (fr)
BE614220A (fr)
BE616247A (fr)
BE616830A (fr)
BE616967A (fr)
BE619061A (fr)
BE620325A (fr)
BE621232A (fr)
BE621517A (fr)
BE622160A (fr)
BE623117A (fr)
BE623162A (fr)